Replies to post #125 on Pharmasset Inc. (fka VRUS)

[oc631]

Citi's analyst raised his 52-week price target from $70 to $200 and said he expects early approval of PSI-7977 in GT2/GT3 in 2014. He originally was calling for approval in 2015???




http://finance.yahoo.com/news/Ahead-of-the-Bell-Pharmasset-apf-1319724263.html?x=0&.v=1